FDA Approves First New Drug To Treat Alzheimer’s Disease In Nearly 20 Years The FDA announced Monday that it is conditionally approving use of Biogen’s monoclonal antibody aducanumab for the treatment of Alzheimer’s disease; it’s the first new drug that has been approved for the disease since 2003.